193 related articles for article (PubMed ID: 38095483)
21. Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations.
Piscitani L; Sirolli V; Di Liberato L; Morroni M; Bonomini M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664269
[TBL] [Abstract][Full Text] [Related]
22. Onconephrology 2022: An Update.
Bonilla M; Gudsoorkar P; Wanchoo R; Herrmann SM; Jhaveri KD
Kidney360; 2023 Feb; 4(2):258-271. PubMed ID: 36821617
[TBL] [Abstract][Full Text] [Related]
23. Nephrotoxicity as a Complication of Chemotherapy and Immunotherapy in the Treatment of Colorectal Cancer, Melanoma and Non-Small Cell Lung Cancer.
Jagieła J; Bartnicki P; Rysz J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924827
[TBL] [Abstract][Full Text] [Related]
24. Pediatric onco-nephrology: time to spread the word : Part I: early kidney involvement in children with malignancy.
Nada A; Jetton JG
Pediatr Nephrol; 2021 Aug; 36(8):2227-2255. PubMed ID: 33245421
[TBL] [Abstract][Full Text] [Related]
25. Onconephrology abstracts and publication trends: time to collaborate.
Thakkar J; Wanchoo R; Jhaveri KD
Clin Kidney J; 2015 Oct; 8(5):629-31. PubMed ID: 26413292
[TBL] [Abstract][Full Text] [Related]
26. Transplant Onconephrology: An Update.
Blosser CD; Portuguese AJ; Santana C; Murakami N
Semin Nephrol; 2022 Nov; 42(6):151348. PubMed ID: 37209580
[TBL] [Abstract][Full Text] [Related]
27. The Current State of Nuclear Nephrology in Modern Medicine.
Miladinova D; Makazlieva T; Peshevska A; Rambabova-Bushljetik I; Poposka D; Majstorov V; Spasovski G
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2023 Dec; 44(3):7-16. PubMed ID: 38109445
[TBL] [Abstract][Full Text] [Related]
28. Is It Time to Integrate Frailty Assessment in Onconephrology?
Wu HHL; Chinnadurai R; Walker RJ; Tennankore KK
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980558
[TBL] [Abstract][Full Text] [Related]
29. Natural products: potential treatments for cisplatin-induced nephrotoxicity.
Fang CY; Lou DY; Zhou LQ; Wang JC; Yang B; He QJ; Wang JJ; Weng QJ
Acta Pharmacol Sin; 2021 Dec; 42(12):1951-1969. PubMed ID: 33750909
[TBL] [Abstract][Full Text] [Related]
30. Nephrotoxicity in cancer treatment: An update.
Chen C; Xie D; Gewirtz DA; Li N
Adv Cancer Res; 2022; 155():77-129. PubMed ID: 35779877
[TBL] [Abstract][Full Text] [Related]
31. Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
Małyszko J; Kozlowski L; Kozłowska K; Małyszko M; Małyszko J
Oncotarget; 2017 Sep; 8(39):66601-66619. PubMed ID: 29029541
[TBL] [Abstract][Full Text] [Related]
32. Nephrotoxic Chemotherapy Agents: Old and New.
Nicolaysen A
Adv Chronic Kidney Dis; 2020 Jan; 27(1):38-49. PubMed ID: 32147000
[TBL] [Abstract][Full Text] [Related]
33. Onco-nephrology: AKI in the cancer patient.
Lam AQ; Humphreys BD
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1692-700. PubMed ID: 22879433
[TBL] [Abstract][Full Text] [Related]
34. [Onconephrology in Renal Transplant Patient: A Challenge for the Transplant Nephrologist].
Sanna E; Manzione AM; Mingozzi S; Biancone L
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007834
[TBL] [Abstract][Full Text] [Related]
35. Onco-nephrology: current concepts and future perspectives.
Kitai Y; Matsubara T; Yanagita M
Jpn J Clin Oncol; 2015 Jul; 45(7):617-28. PubMed ID: 25784734
[TBL] [Abstract][Full Text] [Related]
36. Nephrotoxicity From Molecularly Targeted Chemotherapeutic Agents.
Kala J; Salman LA; Geara AS; Izzedine H
Adv Chronic Kidney Dis; 2021 Sep; 28(5):415-428.e1. PubMed ID: 35190108
[TBL] [Abstract][Full Text] [Related]
37. Acute Kidney Injury in Cancer Immunotherapy Recipients.
Joseph A; Lafarge A; Azoulay E; Zafrani L
Cells; 2022 Dec; 11(24):. PubMed ID: 36552755
[TBL] [Abstract][Full Text] [Related]
38. Cisplatin Nephrotoxicity: Novel Insights Into Mechanisms and Preventative Strategies.
Motwani SS; Kaur SS; Kitchlu A
Semin Nephrol; 2022 Nov; 42(6):151341. PubMed ID: 37182407
[TBL] [Abstract][Full Text] [Related]
39. [Renal Side Effects of Novel Molecular Targeted Oncologic Agents].
Fenoglio R; Cortazzi S; Marchisio M; Rabajoli G; Terzolo E; Sciascia S; Roccatello D
G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007829
[TBL] [Abstract][Full Text] [Related]
40. The basics of onco-nephrology in the renal clinic.
Cosmai L; Porta C; Foramitti M; Rizzo M; Gallieni M
J Nephrol; 2020 Dec; 33(6):1143-1149. PubMed ID: 33242211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
